ATE489098T1 - Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen - Google Patents

Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen

Info

Publication number
ATE489098T1
ATE489098T1 AT05777135T AT05777135T ATE489098T1 AT E489098 T1 ATE489098 T1 AT E489098T1 AT 05777135 T AT05777135 T AT 05777135T AT 05777135 T AT05777135 T AT 05777135T AT E489098 T1 ATE489098 T1 AT E489098T1
Authority
AT
Austria
Prior art keywords
ointment
pharmaceutical composition
active ingredients
dissolved active
pharmaceutical
Prior art date
Application number
AT05777135T
Other languages
English (en)
Inventor
Leslie Zanutto
Sandrine Orsoni
Nathalie Barthez
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Application granted granted Critical
Publication of ATE489098T1 publication Critical patent/ATE489098T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05777135T 2004-06-17 2005-06-15 Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen ATE489098T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0406609A FR2871694B1 (fr) 2004-06-17 2004-06-17 Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
PCT/FR2005/001493 WO2006005842A1 (fr) 2004-06-17 2005-06-15 Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises.

Publications (1)

Publication Number Publication Date
ATE489098T1 true ATE489098T1 (de) 2010-12-15

Family

ID=34946515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05777135T ATE489098T1 (de) 2004-06-17 2005-06-15 Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen

Country Status (14)

Country Link
US (1) US20050281848A1 (de)
EP (1) EP1758588B1 (de)
JP (1) JP2008502661A (de)
CN (1) CN101090725A (de)
AT (1) ATE489098T1 (de)
AU (1) AU2005261569A1 (de)
BR (1) BRPI0511206A (de)
CA (1) CA2567680A1 (de)
DE (1) DE602005024959D1 (de)
ES (1) ES2360469T3 (de)
FR (1) FR2871694B1 (de)
MX (1) MXPA06014407A (de)
RU (1) RU2007101516A (de)
WO (1) WO2006005842A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885527B1 (fr) * 2005-05-16 2007-06-29 Galderma Res & Dev Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
JP2010502624A (ja) * 2006-08-29 2010-01-28 テバ ファーマシューティカル インダストリーズ リミティド 低ｐＨ親和性を有するコルチコステロイド化合物及びビタミンＤ含有化合物を含む安定な薬理活性組成物
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
FR2912655A1 (fr) * 2007-02-15 2008-08-22 Galderma Sa Produit de soin cutane a double compartiment comprenant du calcitriol et du propionate de clobetasol, et son utilisation
EP1970048A1 (de) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topische Zusammensetzung mit Vitamin D
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
US20120004200A1 (en) * 2008-12-23 2012-01-05 Galderma S.A. Topical pharmaceutical composition containing a water-sensitive active principle
EP2515865B1 (de) * 2009-12-22 2016-12-14 Leo Pharma A/S Zusammensetzung für die haut mit vitamin-d-analogon und einer mischung aus einem lösungsmittel und tensiden
AU2010335656B2 (en) * 2009-12-22 2015-05-07 Leo Pharma A/S Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue
WO2012123515A1 (en) 2011-03-14 2012-09-20 Drug Delivery Solutions Limited An ophthalmic composition
CN104666312B (zh) * 2015-02-12 2017-11-07 重庆华邦制药有限公司 含有卡泊三醇和二丙酸倍他米松的制剂
CN108969527B (zh) * 2017-05-31 2021-05-11 上海通用药业股份有限公司 一种药物制剂及其制备方法和用途
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
NZ515142A (en) * 1999-04-23 2004-01-30 Leo Pharm Prod Ltd Pharmaceutical composition
AU9163701A (en) * 2000-10-27 2002-05-06 Leo Pharma As Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
KR20050085787A (ko) * 2002-12-17 2005-08-29 갈데르마 소시에떼아노님 칼시트리올 및 클로베타솔 프로피오네이트의 배합물을함유하는 약학 조성물
US7582307B2 (en) * 2003-11-26 2009-09-01 Harmony Labs, Inc. Dermatological composition

Also Published As

Publication number Publication date
EP1758588B1 (de) 2010-11-24
MXPA06014407A (es) 2007-02-19
WO2006005842A1 (fr) 2006-01-19
AU2005261569A1 (en) 2006-01-19
CN101090725A (zh) 2007-12-19
FR2871694A1 (fr) 2005-12-23
JP2008502661A (ja) 2008-01-31
ES2360469T3 (es) 2011-06-06
DE602005024959D1 (de) 2011-01-05
RU2007101516A (ru) 2008-07-27
CA2567680A1 (fr) 2006-01-19
US20050281848A1 (en) 2005-12-22
EP1758588A1 (de) 2007-03-07
FR2871694B1 (fr) 2008-07-04
BRPI0511206A (pt) 2007-11-27

Similar Documents

Publication Publication Date Title
ATE489098T1 (de) Pharmazeutische zusammensetzung mit einer salbe und zwei aufgelösten wirkstoffen
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
ECSP099387A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
PT2455083E (pt) Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
MX2009000507A (es) Espuma farmaceutica de acidos grasos.
MY137060A (en) Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis
ECSP045407A (es) Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
WO2007011606A3 (en) USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
PA8748101A1 (es) Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
BRPI0411699A (pt) compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
NO20062198L (no) Bradykinin B1 reseptorantagonister
CY1109507T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
DK1166788T3 (da) Lægemidler til ledsygdomme
TW200724132A (en) Versatile high load concentrate compositions for control of ecto-parasites
DE60316724D1 (de) Pharmazeutische zusammensetzung enthaltend calcitriol und clobetasol propionate
TR200103004T2 (tr) Pirolidinkarbonilamino siklik disülfitler.
ATE479693T1 (de) Phosphoindole als hiv-inhibitoren
DE602004017164D1 (de) Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten
AR057648A1 (es) Composicion de metaflumizona para la administracion topica
DE60003188D1 (de) Paracetamol und drotaverin enthaltende zusammensetzung
ITMI20052515A1 (it) Formulazione farmaceutica per il trattamento della osteoartrite
WO2006076119A3 (en) Treatment of skin diseases
ECSP055917A (es) Derivados de diazepanes útiles como inhibidores de lfa

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties